A History of US Medical Device Regulation and Current Regulatory Framework.

JBJS Rev · Jun 01 2026 · Review

Gluski JM, Ward M, Polly DW, Tileston K, Cahill PJ, Ratliff J, et al.

Northwell, New Hyde Park, New York

General Orthopaedics

SUMMARY — THE REDUCTIONFDA medical device regulation has evolved to include real-world data generation for regulatory applications, potentially reducing cost and time-to-market for new devices.
Abstract, as published

» The Food and Drug Administration (FDA) was created in the wake of public outcry generated by Upton Sinclair's The Jungle. The FDA gained further regulatory authority following successive public health setbacks in the 20th century. » A full review for a new device is referred to as a premarket approval (PMA), while an application for a device based on a predicate is referred to as a premarket notification (PMN) better known as a 510k. » Both for PMNs and PMAs the costs and timelines typically far exceed the statutory limits imposed by congress, running into years of review and many millions of dollars. » Real-world data (RWD) can now be used to generate evidence for use in regulatory applications; this change will hopefully reduce the cost and time-to-market for new medical devices. » RWD has significant limitations such as bias, confounding, missing data, and privacy concerns that will require the FDA to take a fit-to-purpose approach for applications using RWD.

Featured in the 2026-07-17 issue.

← The Role of Amino Acid Supplementation in Orthopaedic Surgery.Changes in Trabecular Pattern of the Upper End of the Femur a… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.